123 related articles for article (PubMed ID: 38205811)
1. The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years-Protocol, recruitment status, and baseline characteristics.
Vukusic S; Bourre B; Casey R; Deiva K; Guennoc AM; Lebrun-Frenay C; Leray E; Rollot F; Benyahya L; Girod C; Marignier R; Maillart E
Mult Scler; 2024 Feb; 30(2):216-226. PubMed ID: 38205811
[TBL] [Abstract][Full Text] [Related]
2. Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.
Vukusic S; Casey R; Rollot F; Brochet B; Pelletier J; Laplaud DA; De Sèze J; Cotton F; Moreau T; Stankoff B; Fontaine B; Guillemin F; Debouverie M; Clanet M
Mult Scler; 2020 Jan; 26(1):118-122. PubMed ID: 30541380
[TBL] [Abstract][Full Text] [Related]
3. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.
Wilson S; Calocer F; Rollot F; Fauvernier M; Remontet L; Tron L; Vukusic S; Le Page E; Debouverie M; Ciron J; Ruet A; De Sèze J; Zephir H; Moreau T; Lebrun-Frénay C; Laplaud DA; Clavelou P; Labauge P; Berger E; Pelletier J; Heinzlef O; Thouvenot E; Camdessanché JP; Leray E; Dejardin O; Defer G
Lancet Reg Health Eur; 2023 Jan; 24():100542. PubMed ID: 36426377
[TBL] [Abstract][Full Text] [Related]
4. Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study.
Leblanc S; Roux J; Tillaut H; Le Page E; Leray E
Rev Neurol (Paris); 2021 Dec; 177(10):1250-1261. PubMed ID: 34253346
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
Louapre C; Collongues N; Stankoff B; Giannesini C; Papeix C; Bensa C; Deschamps R; Créange A; Wahab A; Pelletier J; Heinzlef O; Labauge P; Guilloton L; Ahle G; Goudot M; Bigaut K; Laplaud DA; Vukusic S; Lubetzki C; De Sèze J; ; Derouiche F; Tourbah A; Mathey G; Théaudin M; Sellal F; Dugay MH; Zéphir H; Vermersch P; Durand-Dubief F; Françoise R; Androdias-Condemine G; Pique J; Codjia P; Tilikete C; Marcaud V; Lebrun-Frenay C; Cohen M; Ungureanu A; Maillart E; Beigneux Y; Roux T; Corvol JC; Bordet A; Mathieu Y; Le Breton F; Boulos DD; Gout O; Guéguen A; Moulignier A; Boudot M; Chardain A; Coulette S; Manchon E; Ayache SS; Moreau T; Garcia PY; Kumaran D; Castelnovo G; Thouvenot E; Taithe F; Poupart J; Kwiatkowski A; Defer G; Derache N; Branger P; Biotti D; Ciron J; Clerc C; Vaillant M; Magy L; Montcuquet A; Kerschen P; Coustans M; Guennoc AM; Brochet B; Ouallet JC; Ruet A; Dulau C; Wiertlewski S; Berger E; Buch D; Bourre B; Pallix-Guiot M; Maurousset A; Audoin B; Rico A; Maarouf A; Edan G; Papassin J; Videt D
JAMA Neurol; 2020 Sep; 77(9):1079-1088. PubMed ID: 32589189
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol.
Cotton F; Kremer S; Hannoun S; Vukusic S; Dousset V;
J Neuroradiol; 2015 Jun; 42(3):133-40. PubMed ID: 25660217
[TBL] [Abstract][Full Text] [Related]
8. Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
Vukusic S; Rollot F; Casey R; Pique J; Marignier R; Mathey G; Edan G; Brassat D; Ruet A; De Sèze J; Maillart E; Zéphir H; Labauge P; Derache N; Lebrun-Frenay C; Moreau T; Wiertlewski S; Berger E; Moisset X; Rico-Lamy A; Stankoff B; Bensa C; Thouvenot E; Heinzlef O; Al-Khedr A; Bourre B; Vaillant M; Cabre P; Montcuquet A; Wahab A; Camdessanché JP; Tourbah A; Guennoc AM; Hankiewicz K; Patry I; Nifle C; Maubeuge N; Labeyrie C; Vermersch P; Laplaud DA;
JAMA Neurol; 2020 Jan; 77(1):94-102. PubMed ID: 31479149
[TBL] [Abstract][Full Text] [Related]
9. The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers.
Brocard G; Casey R; Dufay N; Marignier R; Michel L; Hisbergues M; Ayrignac X; Lehmann S; Thouvenot E; Gallot G; Collongues N; Herpe YE; Lebrun-Frenay C; Cotton F; De Sèze J; Guillemin F; Moreau T; Pelletier J; Stankoff B; Vukusic S; Zephir H; Laplaud D;
Mult Scler Relat Disord; 2023 Sep; 77():104872. PubMed ID: 37453261
[TBL] [Abstract][Full Text] [Related]
10. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
Gavoille A; Rollot F; Casey R; Debouverie M; Le Page E; Ciron J; De Seze J; Ruet A; Maillart E; Labauge P; Zephir H; Papeix C; Defer G; Lebrun-Frenay C; Moreau T; Laplaud DA; Berger E; Stankoff B; Clavelou P; Thouvenot E; Heinzlef O; Pelletier J; Al Khedr A; Casez O; Bourre B; Cabre P; Wahab A; Magy L; Camdessanche JP; Maurousset A; Moulin S; Ben NH; Boulos DD; Hankiewicz K; Neau JP; Pottier C; Nifle C; Rabilloud M; Subtil F; Vukusic S;
Neurology; 2023 Mar; 100(12):e1296-e1308. PubMed ID: 36564207
[TBL] [Abstract][Full Text] [Related]
11. The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Alwan S; Chambers CD; Armenti VT; Sadovnick AD
Mult Scler Relat Disord; 2015 Jan; 4(1):6-17. PubMed ID: 25787048
[TBL] [Abstract][Full Text] [Related]
12. Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021.
Swital M; Drouin J; Miranda S; Bakchine S; Botton J; Dray-Spira R
Mult Scler; 2024 Feb; 30(2):227-237. PubMed ID: 38281078
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study.
Villaverde-González R; Candeliere-Merlicco A; Alonso-Frías MA; Aparicio Castro E; Carrillo Alcaraz A; Mallada Frechín J; Pérez Sempere Á
Mult Scler Relat Disord; 2020 Nov; 46():102518. PubMed ID: 32977075
[TBL] [Abstract][Full Text] [Related]
14. Predictors of treatment switching in the Big Multiple Sclerosis Data Network.
Spelman T; Magyari M; Butzkueven H; Van Der Walt A; Vukusic S; Trojano M; Iaffaldano P; Horáková D; Drahota J; Pellegrini F; Hyde R; Duquette P; Lechner-Scott J; Sajedi SA; Lalive P; Shaygannejad V; Ozakbas S; Eichau S; Alroughani R; Terzi M; Girard M; Kalincik T; Grand'Maison F; Skibina O; Khoury SJ; Yamout B; Sa MJ; Gerlach O; Blanco Y; Karabudak R; Oreja-Guevara C; Altintas A; Hughes S; McCombe P; Ampapa R; de Gans K; McGuigan C; Soysal A; Prevost J; John N; Inshasi J; Stawiarz L; Manouchehrinia A; Forsberg L; Sellebjerg F; Glaser A; Pontieri L; Joensen H; Rasmussen PV; Sejbaek T; Poulsen MB; Christensen JR; Kant M; Stilund M; Mathiesen H; Hillert J;
Front Neurol; 2023; 14():1274194. PubMed ID: 38187157
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies.
Tillaut H; Degrémont A; Kerbrat S; Roux J; Le Page E; Mainguy C; Duros S; Polard E; Leray E
Mult Scler; 2022 Apr; 28(5):778-789. PubMed ID: 34410176
[TBL] [Abstract][Full Text] [Related]
16. Health care services and disease modifying therapies use in community-based multiple sclerosis patients: Evolution from 2013 to 2015 and demographic characteristics.
Ha-Vinh P; Nauleau S; Clementz M; Régnard P; Sauze L; Clavaud H
Presse Med; 2019 Jan; 48(1 Pt 1):e1-e19. PubMed ID: 30528148
[TBL] [Abstract][Full Text] [Related]
17. Women with female infertility seeking medically assisted reproduction are not at increased risk of developing multiple sclerosis.
Kopp TI; Pinborg A; Glazer CH; Magyari M
Hum Reprod; 2022 May; 37(6):1324-1333. PubMed ID: 35265993
[TBL] [Abstract][Full Text] [Related]
18. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
Oh J; Gagné-Brosseau MS; Guenette M; Larochelle C; Lemieux F; Menon S; Morrow SA; Poliquin-Lasnier L; Roy-Hewitson C; Rush C; Trudelle AM; Giacomini PS
Can J Neurol Sci; 2018 May; 45(3):304-312. PubMed ID: 29756588
[TBL] [Abstract][Full Text] [Related]
19. Untreated patients with multiple sclerosis: A study of French expert centers.
Moisset X; Fouchard AA; Pereira B; Taithe F; Mathey G; Edan G; Ciron J; Brochet B; De Sèze J; Papeix C; Vermersch P; Labauge P; Defer G; Lebrun-Frenay C; Moreau T; Laplaud D; Berger E; Pelletier J; Stankoff B; Gout O; Thouvenot E; Heinzlef O; Al-Khedr A; Bourre B; Casez O; Cabre P; Montcuquet A; Créange A; Camdessanché JP; Bakchine S; Maurousset A; Hankiewicz K; Pottier C; Maubeuge N; Dimitri Boulos D; Nifle C; Vukusic S; Clavelou P;
Eur J Neurol; 2021 Jun; 28(6):2026-2036. PubMed ID: 33650261
[TBL] [Abstract][Full Text] [Related]
20. Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France.
Leblanc S; Lefort M; Le Page E; Michel L; Leray E
Expert Rev Neurother; 2022 May; 22(5):411-418. PubMed ID: 35363999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
